Piperaquine
- Generic Name
- Piperaquine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C29H32Cl2N6
- CAS Number
- 4085-31-8
- Unique Ingredient Identifier
- A0HV2Q956Y
- Background
Piperaquine is an antimalarial agent first synthesized in the 1960's and used throughout China . Its use declined in the 1980's as piperaquine resistant strains of Plasmodium falciparum appeared and artemisinin derivatives became available. It has come back into use in combination with the artemisinin derivative Artenimol as part of the combination product E...
- Indication
For the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg . Used in combination with Artenimol.
- Associated Conditions
- Malaria caused by Plasmodium falciparum
- Associated Therapies
- -
Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Syamsudin Abdillah,Ph.D, Pharm D
- Target Recruit Count
- 50
- Registration Number
- NCT06036030
- Locations
- 🇮🇩
Manokwari Regional General Hospital, Manokwari, West Papua, Indonesia
Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency
- Conditions
- Interventions
- First Posted Date
- 2023-04-25
- Last Posted Date
- 2023-05-16
- Lead Sponsor
- Syamsudin Abdillah,Ph.D, Pharm D
- Target Recruit Count
- 36
- Registration Number
- NCT05829187
- Locations
- 🇮🇩
Kori Puskesmas, Tambolaka, East Nusa Tenggara, Indonesia
Controlled Human Malaria Infection Transmission Model - Phase A
- Conditions
- Interventions
- First Posted Date
- 2020-02-21
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 44
- Registration Number
- NCT04280692
- Locations
- 🇰🇪
KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in Schoolchildren
- Conditions
- Interventions
- First Posted Date
- 2012-11-07
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Universiteit Antwerpen
- Target Recruit Count
- 616
- Registration Number
- NCT01722539
- Locations
- 🇨🇬
Mokali health area of Biyela health zone, in Kinshasa province., Kinshasa, Kinshasa province, Congo
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.